Vertiv (VRT) Q4 2025 earnings review

Order Explosion Redefines Growth Trajectory

Vertiv delivered a pivotal quarter characterized by a stunning 252% YoY increase in organic orders and a book-to-bill ratio of ~2.9x. While Q4 revenue growth (+19% organic) decelerated slightly sequentially, the backlog doubled to $15.0B, effectively locking in FY26 visibility. The narrative has shifted from 'recovery' to 'hyper-growth' driven by AI infrastructure. Profitability followed suit with Adjusted Operating Margins expanding 170bps to 23.2%, overcoming tariff headwinds. FY26 guidance projects an acceleration in revenue growth to ~28%, signaling the massive order intake is about to convert to sales.

๐Ÿ‚ Bull Case

Unprecedented Demand Signal

Organic orders surged 252% YoY, and the book-to-bill ratio hit 2.9x. This is not just growth; it is a step-change in demand velocity driven by hyperscale and AI infrastructure.

Revenue Visibility Secured

Backlog jumped 109% YoY to $15.0 billion. With FY26 revenue guidance midpoint at $13.5 billion, Vertiv has effectively sold out a massive portion of the coming year, reducing commercial risk.

๐Ÿป Bear Case

International Sales Weakness

While the Americas boomed (+50% sales), international markets contracted. APAC sales fell 10% and EMEA fell 8% YoY. Reliance on the Americas has intensified, creating concentration risk.

Execution Risk on Capacity

With a 2.9x book-to-bill, the bottleneck shifts entirely to production capacity. Scaling manufacturing to meet a $15B backlog without incurring inefficiencies or quality issues is a massive operational challenge.

โš–๏ธ Verdict: ๐ŸŸข๐ŸŸข

Strong Buy. The 252% order growth and $15B backlog are game-changing metrics that secure growth through FY26. While international sales lag, the sheer magnitude of the AI capex wave in the Americas outweighs geographic imbalances.

Key Themes

DRIVERNEW๐ŸŸข๐ŸŸข

Hyper-Growth in Orders

Accelerating. Organic order growth went parabolic: from 15% in Q2 to 60% in Q3, culminating in 252% in Q4. This indicates that hyperscalers are aggressively securing future capacity for AI infrastructure. The 2.9x book-to-bill ratio suggests demand is currently stripping supply by nearly 3-to-1.

DRIVERNEW๐ŸŸข

Cash Flow Boost from Advance Payments

Accelerating. Operating Cash Flow hit $1.0B in Q4 (+136% YoY). A key driver noted was 'project-related advanced payments.' This implies customers are so desperate for capacity they are prepaying to reserve slots, effectively funding Vertiv's working capital needs for growth.

CONCERNโšช

Regional Bifurcation

Decelerating. The Americas region is the sole engine of current revenue growth, up 50% YoY. Conversely, APAC sales dropped 10% and EMEA fell 8%. While management cites broad-based order growth, the revenue conversion in international markets is currently acting as a drag on the consolidated top line.

DRIVER๐ŸŸข

Margin Expansion Continuation

Accelerating. Adjusted Operating Margin reached 23.2%, up 170 bps YoY and up 90 bps sequentially. This expansion occurred despite reported tariff headwinds, confirming that pricing power and volume leverage are currently outpacing input cost pressures. FY26 guidance implies stable-to-rising margins at 22-23%.

THEMEโšช

Tariff Costs vs. Pricing Power

Stable. The report cites 'favorable price-cost, partially offset by tariff impact.' While tariffs remain a headwind, the 23.2% margin result suggests Vertiv has successfully passed these costs on to customers, likely aided by the tight supply environment indicated by the high book-to-bill ratio.

Other KPIs

Adjusted Diluted EPS (25Q4)$1.36

Accelerating. Up 37% YoY from $0.99 in 24Q4. The sequential acceleration in earnings power is evident, significantly outpacing the 19% organic revenue growth, demonstrating strong operating leverage.

Americas Net Sales (25Q4)$1.89 billion

Accelerating. Growth surged to 50% YoY, accounting for 65% of total revenue. This concentration underscores that the AI infrastructure boom is currently a US-centric phenomenon for Vertiv's P&L.

Net Leverage (25Q4)0.5x

Improving. Down from 1.0x a year ago. Strong cash generation and EBITDA growth have de-risked the balance sheet, providing ample capacity for the $1B in strategic acquisitions deployed during the quarter.

Guidance

FY26 Net Sales$13.25 - $13.75 billion

Accelerating. The midpoint implies ~28% organic growth, a significant acceleration from the 19% organic growth delivered in 25Q4. This confirms management expects the massive backlog to convert rapidly into revenue.

FY26 Adjusted Operating Profit$2.98 - $3.10 billion

Accelerating. Midpoint represents ~45% YoY growth vs FY25 ($2.09B). This implies operating margins of ~22.5%, maintaining the high-water mark set in late 2025 despite massive volume ramping.

26Q1 Organic Net Sales Growth18% - 26%

Stable. The midpoint (22%) is roughly in line with the 25Q4 exit rate (19%) and consistent with FY26 full-year guidance, suggesting no immediate air pocket in demand.

Key Questions

Capacity Constraints

With a book-to-bill of 2.9x and a $15B backlog, what are the specific bottlenecks to converting this to revenue faster? Is the 28% growth cap dictated by internal manufacturing limits or customer site readiness?

International Divergence

Americas sales grew 50% while APAC and EMEA shrank. Is this solely due to project timing and macro weakness, or are you losing market share in international territories?

Advance Payments Sustainability

Operating cash flow benefited significantly from customer advanced payments. Is this a permanent structural change in contract terms due to scarcity, or a one-time liquidity boost?

Tariff Mitigation in 2026

Margins are strong, but tariffs were cited as a headwind. What is the assumed net impact of tariffs in the FY26 guidance, and how much pricing coverage is already locked into the backlog?